Skip to content

Study of Nasal Mucosa Histopathological Changes in Chronic Hypersensitivity Pneumonitis

Study of Nasal Mucosa Histopathological Changes in Patients With Chronic Hypersensitivity Pneumonitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05723796
Enrollment
40
Registered
2023-02-13
Start date
2021-07-01
Completion date
2022-12-15
Last updated
2023-02-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypersensitivity Pneumonitis, Nasal Mucosal Disorder

Keywords

hypersensitivity pneumonitis, nasal mucosa histopaholgical changes

Brief summary

Background:Hypersensitivity pneumonitis (HP) is an interstitial lung disease that develops after inhalation of organic or inorganic antigens in susceptible individuals. The nasal mucosa is constantly exposed to these antigens that can irritate the respiratory mucosa. Objectives: to assess the burden of sinonasal symptoms in HP patients and to evaluate the nasal histopathology in those patients.

Interventions

nasal endoscopy and mucosal biopsy

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
29 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* all patients with clinical and radiological features of HP

Exclusion criteria

* respiratory failure * patients on anticoagulants

Design outcomes

Primary

MeasureTime frameDescription
percentage of patients with HP developed nasal mucosa granuloma and lymphocytic infiltrations as detected by nasal endoscopy6 monthsnasal endoscopy and nasal mucosa biopsy was done for all patients to measure the % of patients with nasal granuloma and lymphocytic infiltrations

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026